← Eichor
Study identifier: NCT06606366 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

Condition: Neoplasm Malignant  ·  Sponsor: Centre Antoine Lacassagne

PhaseNA
Planned participants238
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will evaluate the diagnostic performance of liquid biopsy for identifying molecular abnormalities among patients managed by the Multidisciplinary Molecular Biology Meeting. The gold standard considered in this study is the solid biopsy.

This description comes directly from the study's public registry record.

Talk to the study team

Study coordinator  ·  +33 04 92 03 14 76  ·  DRCI-Promotion@nice.unicancer.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Antoine LacassagneNice, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06606366